학술논문
Correction to: A randomized, multicentre, open-label phase II proof-of-concept trial investigating the clinical efficacy and safety of the addition of convalescent plasma to the standard of care in patients hospitalized with COVID-19: the Donated Antibodies Working against nCoV (DAWn-Plasma) trial
Document Type
article
Author
Timothy Devos; Tatjana Geukens; Alexander Schauwvlieghe; Kevin K. Ariën; Cyril Barbezange; Myriam Cleeren; Veerle Compernolle; Nicolas Dauby; Daniël Desmecht; David Grimaldi; Bart N. Lambrecht; Anne Luyten; Piet Maes; Michel Moutschen; Marta Romano; Lucie Seyler; Michel Toungouz Nevessignsky; Katleen Vandenberghe; Johan van Griensven; Geert Verbeke; Erika Vlieghe; Jean Cyr Yombi; Laurens Liesenborghs; Peter Verhamme; Geert Meyfroidt
Source
Trials, Vol 21, Iss 1, Pp 1-1 (2020)
Subject
Language
English
ISSN
1745-6215
Abstract
An amendment to this paper has been published and can be accessed via the original article.